| [1] |
Airoldi M, Gabriele AM, Garzaro M,et al. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population[J].Radiother Oncol, 2009,92(1): 105-10.
|
| [2] |
Lu H, Peng L, Yuan X, et al. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia[J]. Cancer Treat Rev, 20 09, 35(4): 345-53.
|
| [3] |
Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin- radiotherapy compared with radiotherapy alone in local regionally advanced nasopharyngeal carcinoma[J].J Nati Cancer Inst,2005,97(7):536-9.
|
| [4] |
Lin JC, Jan JS, Hsu CY, et al. Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis [J]. Cancer, 1998,83(4):635-40.
|
| [5] |
Yang ES, Murphy BM, Chung CH, et al. Evolution of clinical trials in head and neck cancer[J].Crit Rev Oncol Hematol, 20 09,71(1):29-42.
|
| [6] |
Zhang L,Zhang Y,Huang PY,et al. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy[J]. Cancer Chemother Pharmacol,2008, 61(1):33-8.
|
| [7] |
Chi KH, Chang YC, Chan WK, et al. A Phase II study of carboplatin in nasopharyngeal carcinoma[J].Oncology, 19 97,54(3):203-7.
|
| [8] |
Tan EH, Khoo KS, Wee J, et al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma[J]. Ann Oncol, 1999,10(2):235-7.
|
| [9] |
Ma BB, Tannock IF, Pond GR,et al. Chemotherapy with gemcitabine-containing regimens for locally recurrent or me t a s t a t i c na sopha rynge a l c a r c inoma [ J ] . Canc e r, 20 02,95(12):2516-23.
|
| [10] |
Edge S, Byrd DR, Compton CC,et al. AJCC Cancer Staging Manual[S]. 7th ed. New York: Springer, 2010.
|
| [11] |
International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy (Suppl ement to ICRU report 50 ) [J]. Bethesda: ICRU, 1999.
|
| [12] |
Mao YP, Li WF, Chen L,et al. A clinical verification of the Chinese 20 08 staging system for nasopharyngeal carcinoma[J]. Ai Zheng, 20 09,28(10):1022-8. [毛燕萍,李文斐,陈磊,等.鼻咽癌2008分期 的临床验证[J].癌症,2009,28(10):1022-8. ]
|
| [13] |
Eisenhauer EA, Therasse P, Bogaerts J,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version1.1) [J]. Eur J Cancer, 2009, 45(2):228-47.
|
| [14] |
Siu LL, Czaykowski PM, Tannock IF. Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx[J]. J Clin Oncol, 1998,16(7): 25 14-21.
|
| [15] |
Hasbini A, Mahjoubi R, Fandi A,et al. Phase Ⅱ trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of the nasopharyngeal type[J]. Ann Oncol, 1999,10(4):421-5.
|
| [16] |
Taamma A, Fandi A, Azli N, et al. Phase Ⅱ trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type[J]. Cancer, 19 99, 86(7):1101-8.
|
| [17] |
Leong SS,Wee J,Rajan S,et al.Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma[J]. Cancer, 2008, 113(6):1332-7.
|
| [18] |
Yu JP, Sun SP, Ni XC, et al. Effectiveness and safety of paclitaxel liposomes plus cisplatin combined with radiotherapy for malignant tumors[J]. Ai Zheng Jin Zhan, 2010,8(2): 180-2,188. [于静萍, 孙 苏平, 倪新初,等. 紫杉醇脂质体加顺铂联合放疗治疗恶性肿瘤 的疗效和安全性研究[J].癌症进展,2010,8(2): 180-2,188.]
|
| [19] |
Chen L,Zhuang ZX,Tao JL,et al.Efficacy and safety of weekly liposome-paclitaxel combined with tegafur on metastatic gastric cancer[J].Zhong Liu Fang Zhi Yan Jiu,2013,40(5):478-80.[ 陈蕾, 庄志祥,陶家龙,等.每周脂质体紫杉醇联合替吉奥胶囊治疗晚期 胃癌的临床疗效及安全性[J].肿瘤防治研究,2013,40(5):478-80.]
|
| [20] |
Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P,et al. Chemora diation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial[J]. Eur J Cancer, 2007, 43(9):1399-406.
|
下载:
